Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9)

Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors

Lois B. Travis, Sophie D. Fosså, Sara J. Schonfeld et al. · JNCI Journal of the National Cancer Institute · 2005 · 827 citations · Full text

Immature (malignant) teratoma of the ovary.A clinical and pathologic study of 58 cases

Henry J. Norris, Howard J. Zirkin, William L. Benson · Cancer · 1976 · 631 citations

Actuarial Survival, Pathologic Study, Tumoral Pathology +12

Treatment-Specific Risks of Second Malignancies and Cardiovascular Disease in 5-Year Survivors of Testicular Cancer

Alexandra W. van den Belt‐Dusebout, Ronald de Wit, Jourik A. Gietema et al. · Journal of Clinical Oncology · 2007 · 456 citations · Full text

Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group.

Stephen Williams, J A Blessing, S Y Liao et al. · Journal of Clinical Oncology · 1994 · 341 citations

Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin.

David M. Gershenson, Michael B. Morris, J. J. Kavanagh et al. · Journal of Clinical Oncology · 1990 · 266 citations

Residual Disease, Gynecologic Surgery, Surgical Oncology +13